Heart failure is a condition where the heart muscle can no longer pump enough blood to meet the body’s needs. When it reaches an advanced stage, certain clinical signs indicate a deterioration that no longer responds to standard treatments. Identifying these signals allows family members and caregivers to adjust the care approach, particularly by focusing on the patient’s comfort.
I-NEED-HELP Score: a tool to identify the transition to end-stage heart failure
The challenge with heart failure lies in its unpredictable trajectory. A patient may alternate between phases of relative stability and episodes of acute decompensation for months or even years. Distinguishing a reversible exacerbation from an irreversible decline requires concrete benchmarks.
The mnemonic acronym I-NEED-HELP was designed to assist cardiology teams in detecting when the disease transitions to a terminal phase. Each letter corresponds to a specific clinical criterion:
- I for recurrent or continuous intravenous inotropes, indicating that the heart can no longer maintain sufficient output on its own
- N for persistent NYHA class III-IV, meaning shortness of breath with minimal exertion or at rest despite treatment
- E for edema or fluid overload resistant to high-dose diuretics
- E for very low ejection fraction or persistently very high biomarkers (BNP, NT-proBNP)
- D for implantable defibrillator triggering repeated shocks
- H for multiple hospitalizations, at least two episodes of heart failure decompensation in the last twelve months
- E for escalation of diuretics without lasting improvement
- L for chronically low systolic blood pressure, often below 90 mmHg
- P for poor short-term prognosis despite therapeutic optimization
When several of these criteria are met, discussing a shift towards palliative care becomes relevant. Better understanding the precursors of imminent death in cases of heart failure helps anticipate this transition rather than facing it in an emergency.
Physical symptoms of worsening: shortness of breath, edema, and extreme fatigue
Several bodily signs, taken in isolation, may seem familiar to patients who have been living with heart failure for a long time. It is their accumulation and resistance to treatment that mark the entry into a terminal phase.
Refractory dyspnea and nocturnal orthopnea
Shortness of breath is no longer limited to exertion. The patient experiences respiratory discomfort at rest, including while sitting. At night, lying down causes a feeling of suffocation that forces them to sleep almost sitting up, with several pillows. Diuretics and oxygen provide only partial and temporary relief.
Persistent fluid accumulation
Fluid accumulation in the tissues manifests as edema in the ankles, legs, and sometimes the abdomen. At an advanced stage, high-dose diuretics can no longer reduce this retention. The patient’s weight may fluctuate significantly from day to day. The appearance of a pleural effusion (fluid around the lungs) further exacerbates dyspnea.
Deep fatigue and loss of autonomy
The weakened heart no longer supplies enough blood to the muscles and organs. The patient feels a fatigue that does not improve with rest or sleep. Daily activities (getting up, washing, eating) become exhausting. Near-complete dependence for activities of daily living serves as a reliable marker of end-stage heart failure.
Organ failures associated with advanced heart failure
The heart is not the only organ affected. When the cardiac pump weakens persistently, other organs suffer the consequences of inadequate blood perfusion.
The kidneys are often the first to be affected. Renal function gradually deteriorates, a condition known as cardiorenal syndrome. The decrease in renal filtration leads to an accumulation of waste in the blood and worsens fluid retention, creating a vicious cycle. Chronic hypotension often accompanies this picture, making it difficult to continue certain necessary cardiac medications.
The liver may also suffer from passive congestion. Blood stagnates upstream of the right heart, causing sometimes painful hepatic swelling. In severe cases, hepatic biological abnormalities appear.
The 2026 recommendations from the European Society of Cardiology (ESC) emphasize that the combination of hypotension, renal and hepatic failure with repeated hospitalizations should guide the care team towards a discussion about prognosis and care goals.
Neuropsychological signs and confusion at the end of cardiac life
Beyond physical symptoms, cognitive and psychological changes signal a major deterioration. Reduced cerebral blood flow can cause episodes of confusion, disorientation, or unusual drowsiness. These disturbances are not always recognized as related to heart failure by those around the patient.
Anxiety and depression often intensify in the final months. Social isolation due to loss of autonomy exacerbates this state of overall suffering. A marked loss of appetite, accompanied by weight loss, indicates a state of cardiac cachexia where the body consumes its own reserves.
Cardiac cachexia is an independent poor prognostic factor, distinct from simple age-related weight loss. It reflects chronic inflammation and hypermetabolism caused by the failing heart.
Adapting palliative care for heart failure patients
Palliative care does not mean abandoning treatment. It aims to relieve dyspnea, pain, anxiety, and sleep disturbances while respecting the patient’s wishes. Current recommendations encourage an early introduction of this approach, well before the final days of life, as soon as the criteria for advanced heart failure are identified.
Home care, particularly through palliative home hospitalization (HAD), allows patients to remain in their familiar environment. Medication adjustments are made with a focus on comfort rather than biological correction. Diuretics are maintained to limit respiratory discomfort, but heavy treatments whose side effects degrade quality of life can be reduced.
Recognizing these warning signs remains the first step in initiating a conversation with the medical team about the desired level of intervention. Each situation is unique, and care goals deserve to be reevaluated as the disease progresses.